Avantor, Inc.

Equities

AVTR

US05352A1007

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 21:00:02 10/12/2025 GMT			5-day change	1st Jan Change
11.51 ^USD	+8.28%		-8.68%	-49.55%

12-04	Avantor, Inc. Appoints Sanjeev Mehra to Its Board of Directors, Effective December 4, 2025	CI
11-19	Avantor® expands centralized service center model with opening of Boston-area facility	RE

Health Care Up as Traders Return to Beaten-Down Stocks -- Health Care Roundup

Published on 08/11/2025 at 09:33 pm BST

Dow Jones

Avantor, Inc.

+8.28%

Eli Lilly and Company

+1.16%

UnitedHealth Group Inc.

+1.47%

Compass Therapeutics, Inc.

+2.14%

Health-care companies ticked up as traders rotated back into the beaten-down sector.

Shares of Eli Lilly and UnitedHealth Group, among other companies that have recently seen major downdrafts in their shares, rebounded Monday.

U.S.-listed shares of domestic and Canadian cannabis companies jumped after The Wall Street Journal reported that President Trump is considering reclassifying marijuana as a less dangerous drug. Canopy Growth surged by more than 25%, while Tilray rose almost 40%.

Activist investor Engine Capital has built a stake in Avantor and plans to push the life-sciences company to make major changes or sell itself.

Shares of Compass Therapeutics rose after one of the biopharmaceutical company's cancer-drug candidates showed promise in a clinical trial.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

08-11-25 1833ET

Stocks mentioned in the article

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
AVANTOR, INC.	11.51USD	+8.28%	-8.68%	7.25B
ELI LILLY AND COMPANY	993.64USD	+1.16%	-3.86%	879B
UNITEDHEALTH GROUP INC.	328.37USD	+1.47%	-3.34%	293B
COMPASS THERAPEUTICS, INC.	5.250USD	+2.14%	-0.57%	914M

Latest news about Avantor, Inc.

12-04	Avantor, Inc. Appoints Sanjeev Mehra to Its Board of Directors, Effective December 4, 2025	CI
11-19	Avantor® expands centralized service center model with opening of Boston-area facility	RE
11-19	Avantor, Inc. Expands Centralized Service Center Model with Opening of Boston-Area Facility	CI
11-10	Avantor Names Mary Blenn COO	MT
11-10	Avantor, Inc. Appoints Mary Blenn as Executive Vice President and Chief Operating Officer, Effective November 10, 2025	CI
11-04	The Bull Market Meets Its Therapist
11-04	Raymond James Downgrades Avantor to Market Perform From Outperform	MT
11-04	Analysts recommendations: Apple, Comcast, Crocs, Eli Lilly, Palantir…
10-31	Avantor Insider Bought Shares Worth $1,125,000, According to a Recent SEC Filing	MT
10-30	Avantor Shares Fall After JPMorgan, Barclays Downgrades	MT
10-30	Avantor, Inc. Unveils Next-Generation Sterile Sampling Platform and PUPSIT Assemblies	CI
10-30	Still Standing, Slightly Wobbly
10-30	JPMorgan Downgrades Avantor to Neutral From Overweight, Adjusts Price Target to $12 From $14	MT
10-30	Barclays Downgrades Avantor to Equalweight From Overweight, Adjusts Price Target to $12 From $15	MT
10-30	Analyst recommendations: Boeing, Alphabet, Caterpillar, Chipotle, Wayfair…
10-29	Avantor, Inc. announces an Equity Buyback for $500 million worth of its shares.	CI
10-29	Avantor, Inc., Q3 2025 Earnings Call, Oct 29, 2025
10-29	Avantor, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
10-29	Avantor, Inc. Provides Earnings Guidance for the Full Year 2025	CI
10-29	Top Premarket Decliners	MT
10-29	Avantor Q3 Adjusted Earnings, Sales Fall	MT
10-29	Lab equipment maker Avantor's Q3 sales miss estimates, announces $500 mln share repurchase	RE
10-29	Earnings Flash (AVTR) Avantor, Inc. Reports Q3 Revenue $1.62B, vs. FactSet Est of $1.65B	MT
10-29	Earnings Flash (AVTR) Avantor, Inc. Posts Q3 Adjusted EPS $0.22 per Share, vs. FactSet Est of $0.22	MT
10-23	Avantor Collaborates With P-Chip for Smart Consumables Line	MT

Chart Avantor, Inc.

Duration

Period

AVTR: Dynamic Chart

Company Profile

Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Companyâs segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.

Employees

13,500

Sector

Medical Equipment, Supplies & Distribution

Calendar

01-28 - Q4 2025 Earnings Release (Projected)

More about the company